BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35968869)

  • 1. Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
    Gantenberg JR; van Aalst R; Zimmerman N; Limone B; Chaves SS; La Via WV; Nelson CB; Rizzo C; Savitz DA; Zullo AR
    J Infect Dis; 2022 Aug; 226(Suppl 2):S164-S174. PubMed ID: 35968869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
    Simões EAF; Madhi SA; Muller WJ; Atanasova V; Bosheva M; Cabañas F; Baca Cots M; Domachowske JB; Garcia-Garcia ML; Grantina I; Nguyen KA; Zar HJ; Berglind A; Cummings C; Griffin MP; Takas T; Yuan Y; Wählby Hamrén U; Leach A; Villafana T
    Lancet Child Adolesc Health; 2023 Mar; 7(3):180-189. PubMed ID: 36634694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).
    Straňák Z; Saliba E; Kosma P; Posfay-Barbe K; Yunis K; Farstad T; Unnebrink K; van Wyk J; Wegzyn C; Notario G; Kalus S; Campbell FJ
    PLoS One; 2016; 11(6):e0157446. PubMed ID: 27310438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month.
    Gantenberg JR; van Aalst R; Bhuma MR; Limone B; Diakun D; Smith DM; Nelson CB; Bengtson AM; Chaves SS; La Via WV; Rizzo C; Savitz DA; Zullo AR
    J Pediatric Infect Dis Soc; 2024 Jun; 13(6):317-327. PubMed ID: 38738450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of multiple prevention strategies for respiratory syncytial virus infections in infants and high-risk toddlers in the United States.
    Ektare V; Lang J; Choi Y; Finelli L
    Vaccine; 2022 Oct; 40(42):6064-6073. PubMed ID: 36096968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Burden of Respiratory Syncytial Virus in Children Under 2 Years of Age in a Rural Community in Maharashtra, India.
    Satav A; Crow R; Potdar V; Dani V; Satav S; Chadha M; Hessong D; Carosone-Link P; Palaskar S; Simões EAF
    Clin Infect Dis; 2021 Sep; 73(Suppl_3):S238-S247. PubMed ID: 34472575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US).
    Nelson CB; Brady BL; Richards M; Lew CR; Via W; Greenberg M; Rizzo C
    Vaccine; 2023 Sep; 41(40):5820-5824. PubMed ID: 37586957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Respiratory Syncytial Virus Infections in Moderate/Late Premature Infants in Turkey: A Prospective Multicenter Epidemiological Study.
    Ozkan H; Celebi S; Koksal N; Hacımustafaoğlu M; Koc E; Tezer H; Cetinkaya M; Cebeci B; Erdeve O; Ozdemir H;
    Am J Perinatol; 2021 Dec; 38(14):1540-1546. PubMed ID: 32659789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.
    Maksić H; Heljić S; Skokić F; Šumanović-Glamuzina D; Milošević V; Zlatanović A; Gerard N
    Bosn J Basic Med Sci; 2018 Aug; 18(3):279-288. PubMed ID: 29750895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outbreak of RSV infections in a neonatology clinic during the RSV-season.
    Vakrilova L; Nikolova SH; Slavov S; Radulova P; Slancheva B
    BMC Pediatr; 2021 Dec; 21(1):567. PubMed ID: 34895173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.
    Carbonell-Estrany X; Bont L; Doering G; Gouyon JB; Lanari M
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):891-9. PubMed ID: 18629558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    Chirikov VV; Simões EAF; Kuznik A; Kwon Y; Botteman M
    J Infect Dis; 2020 Mar; 221(8):1244-1255. PubMed ID: 30982895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.
    Kong AM; Krilov LR; Fergie J; Goldstein M; Diakun D; Wade SW; Pavilack M; McLaurin KK
    Am J Perinatol; 2018 Jan; 35(2):192-200. PubMed ID: 28881376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
    Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
    Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Fleming-Dutra KE; Jones JM; Roper LE; Prill MM; Ortega-Sanchez IR; Moulia DL; Wallace M; Godfrey M; Broder KR; Tepper NK; Brooks O; Sánchez PJ; Kotton CN; Mahon BE; Long SS; McMorrow ML
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(41):1115-1122. PubMed ID: 37824423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study.
    Papenburg J; Defoy I; Massé E; Caouette G; Lebel MH
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):237-244. PubMed ID: 32530035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017.
    Simões EAF; Botteman M; Chirikov V
    J Infect Dis; 2024 Apr; 229(4):1112-1122. PubMed ID: 37625899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
    Griffin MP; Yuan Y; Takas T; Domachowske JB; Madhi SA; Manzoni P; Simões EAF; Esser MT; Khan AA; Dubovsky F; Villafana T; DeVincenzo JP;
    N Engl J Med; 2020 Jul; 383(5):415-425. PubMed ID: 32726528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
    Madhi SA; Kuwanda L; Cutland C; Klugman KP
    J Clin Virol; 2006 Jul; 36(3):215-21. PubMed ID: 16678480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.